Wells Fargo’s Corvus Pharmaceuticals CRVS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $108K | Buy |
27,070
+25,070
| +1,254% | +$100K | ﹤0.01% | 4739 |
|
|
2025
Q1 | $6.36K | Buy |
2,000
+1,831
| +1,083% | +$5.82K | ﹤0.01% | 5513 |
|
|
2024
Q4 | $904 | Buy |
+169
| New | +$904 | ﹤0.01% | 5763 |
|
|
2024
Q2 | – | Sell |
-265
| Closed | -$472 | – | 6599 |
|
|
2024
Q1 | $472 | Buy |
265
+5
| +2% | +$9 | ﹤0.01% | 5898 |
|
|
2023
Q4 | $458 | Buy |
260
+13
| +5% | +$23 | ﹤0.01% | 5961 |
|
|
2023
Q3 | $361 | Sell |
247
-1
| -0.4% | -$1 | ﹤0.01% | 6058 |
|
|
2023
Q2 | $568 | Buy |
248
+10
| +4% | +$23 | ﹤0.01% | 6148 |
|
|
2023
Q1 | $217 | Buy |
238
+3
| +1% | +$3 | ﹤0.01% | 6432 |
|
|
2022
Q4 | $200 | Buy |
235
+6
| +3% | +$5 | ﹤0.01% | 6295 |
|
|
2022
Q3 | $0 | Buy |
229
+11
| +5% | – | ﹤0.01% | 6413 |
|
|
2022
Q2 | $0 | Buy |
+218
| New | – | ﹤0.01% | 6577 |
|
|
2021
Q4 | – | Sell |
-182
| Closed | -$1K | – | 6711 |
|
|
2021
Q3 | $1K | Buy |
182
+17
| +10% | +$93 | ﹤0.01% | 6343 |
|
|
2021
Q2 | $0 | Buy |
165
+1
| +0.6% | – | ﹤0.01% | 6587 |
|
|
2021
Q1 | $1K | Buy |
164
+60
| +58% | +$366 | ﹤0.01% | 6324 |
|
|
2020
Q4 | $0 | Buy |
104
+6
| +6% | – | ﹤0.01% | 6164 |
|
|
2020
Q3 | $0 | Buy |
98
+19
| +24% | – | ﹤0.01% | 5996 |
|
|
2020
Q2 | $0 | Hold |
79
| – | – | ﹤0.01% | 5929 |
|
|
2020
Q1 | $0 | Buy |
+79
| New | – | ﹤0.01% | 5896 |
|
|
2019
Q3 | – | Sell |
-676
| Closed | -$3K | – | 5900 |
|
|
2019
Q2 | $3K | Sell |
676
-24,339
| -97% | -$108K | ﹤0.01% | 5675 |
|
|
2019
Q1 | $101K | Sell |
25,015
-16
| -0.1% | -$65 | ﹤0.01% | 5040 |
|
|
2018
Q4 | $92K | Buy |
25,031
+21,049
| +529% | +$77.4K | ﹤0.01% | 5081 |
|
|
2018
Q3 | $34K | Buy |
3,982
+430
| +12% | +$3.67K | ﹤0.01% | 5393 |
|
|
2018
Q2 | $39K | Buy |
3,552
+370
| +12% | +$4.06K | ﹤0.01% | 5371 |
|
|
2018
Q1 | $37K | Buy |
3,182
+19
| +0.6% | +$221 | ﹤0.01% | 5343 |
|
|
2017
Q4 | $33K | Sell |
3,163
-3,777
| -54% | -$39.4K | ﹤0.01% | 5347 |
|
|
2017
Q3 | $111K | Buy |
6,940
+3,534
| +104% | +$56.5K | ﹤0.01% | 4972 |
|
|
2017
Q2 | $41K | Buy |
3,406
+6
| +0.2% | +$72 | ﹤0.01% | 5167 |
|
|
2017
Q1 | $71K | Buy |
3,400
+2,500
| +278% | +$52.2K | ﹤0.01% | 5069 |
|
|
2016
Q4 | $13K | Sell |
900
-500
| -36% | -$7.22K | ﹤0.01% | 5396 |
|
|
2016
Q3 | $23K | Buy |
1,400
+700
| +100% | +$11.5K | ﹤0.01% | 5276 |
|
|
2016
Q2 | $10K | Buy |
+700
| New | +$10K | ﹤0.01% | 5381 |
|